Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ngm Biopharmaceuticals Inc (NQ: NGM )

0.8053 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ngm Biopharmaceuticals Inc

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Acorda Therapeutics (NASDAQ:ACOR) shares increased by 46.1% to $0.49 during Monday's pre-market session. The company's market cap stands at $11.9 million. 
Via Benzinga
NGM Bio Announces Topline Results from the CATALINA Phase 2 Trial of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
NGM Bio to Host Conference Call to Discuss Topline Results from the CATALINA Phase 2 Trial of NGM621 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
NGM Bio Presents Preliminary Data From NGM120 Combo Trial In Pancreatic Cancer
Via Benzinga
NGM Bio To Highlight Updated Preliminary Findings From Advanced Solid Tumors Trial
Via Benzinga
Poshmark, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning after recording gains in the previous session. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket
Gainers Bit Brother Limited (NASDAQ: BTB) rose 91.7% to $0.2150 in pre-market trading after declining around 14% on Monday. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
NGM Biopharmaceuticals's Return On Capital Employed Insights
Benzinga Pro data, NGM Biopharmaceuticals (NASDAQ:NGM) reported Q2 sales of $8.29 million. Earnings fell to a loss of $46.52 million, resulting in a 43.36% decrease from last quarter. 
Via Benzinga
Short Volatility Alert: NGM Biopharmaceuticals, Inc.
On Friday, shares of NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) experienced volatile short activity. After the activity, the stock price went up +3.21% to $15.74. The overall sentiment for NGM has been... 
Via Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Executives Buy Over $15M Of 3 Stocks
Although the Dow Jones dropped around 875 points on Monday, there were a few notable insider trades. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers 
Via Benzinga
Insiders Buy Around $10M Of 3 Stocks
Although the Dow Jones jumped more than 400 points on Thursday, there were a few notable insider trades. 
Via Benzinga
NGM Bio Initiates NGM438 Phase 1/1b trial for advanced solid tumors
NGM Biopharmaceuticals, Inc. (NGM Bio) (NASDAQ: NGM) initiated a Phase 1/1b clinical study of its drug candidate NGM438 for the treatment of patients with advanced solid tumors. 
Via Benzinga
NGM Biopharmaceuticals's Return On Capital Employed Overview
According to Benzinga Pro data, during Q4, NGM Biopharmaceuticals (NASDAQ:NGM) posted sales of $20.96 million. Earnings were up 5.65%, but NGM Biopharmaceuticals still reported an... 
Via Benzinga
NGM Bio Shares Rise After Vision Disorder Candidate Receives FDA Fast Track Tag
The FDA has granted Fast Track designation to NGM Biopharmaceuticals Inc's 
Via Benzinga
55 Biggest Movers From Friday
Gainers Takung Art Co., Ltd. (NASDAQ: TKAT) surged 61.8% to close at $3.64 on Friday. Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) rose 43.8% to settle at $11.49... 
Via Benzinga
Is Good News Enough for You to Buy NGM on the Dip?
A drop in the overall market provides an opportunity for investors to pounce. 
Via The Motley Fool
10 Biggest Price Target Changes For Friday
UBS cut FedEx Corporation (NYSE:FDX) price target fr... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 90 companies set new 52-week lows. Areas of Significance In Today's 52-Week Lows: The company with the largest market cap to set a new 52-week low was... 
Via Benzinga
NGM Bio Presents Preliminary Data From NGM120 Solid Tumor Trial
NGM Biopharmaceuticals Inc (NASDAQ: NGM) announced preliminary findings from its ongoing Phase 1a/1b dose-escalation study of NGM120 in solid tumors. Related Link... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead... 
Via Benzinga
Raymond James Upgraded This Biopharma Stock And Sees 44% Upside
Raymond James has upgraded NGM Biopharmaceuticals Inc (NASDAQ: 
Via Benzinga
45 Stocks Moving In Monday's Mid-Day Session
Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Keybanc lowered the price target on FedEx Corporation (NYSE: FDX) from $370 to $350. FedEx shares rose 0.6% to $259.00 in pre-market trading. Telsey Advisory Group raised the... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2021
Upgrades For Bank of America Corp (NYSE: 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.